23 results
8-K
EX-99.1
VRCA
Verrica Pharmaceuticals Inc
10 Aug 21
Verrica Pharmaceuticals Reports Second Quarter 2021 Financial Results
8:01am
leadership team and ensuring patient access to VP-102 through productive dialogue with medical providers and payors,” said Ted White, Verrica’s President
8-K
EX-99.1
n3wqahttkqo
6 Jan 21
Regulation FD Disclosure
6:05am
8-K
EX-99.2
axqulet3
10 Nov 20
Regulation FD Disclosure
7:52am
8-K
EX-99.1
8k6zdem
8 Sep 20
Regulation FD Disclosure
7:01am
8-K
EX-99.1
9sznf9
5 Aug 20
Verrica Pharmaceuticals Reports Second Quarter 2020 Financial Results
7:28am
8-K
EX-99.1
ftd wk10mqirx
23 Jul 20
Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes
7:45am
8-K
EX-99.1
o9y2p
10 Jun 20
Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors
7:41am
8-K
EX-99.1
uhsxz677zms
13 Mar 20
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
4:05pm
8-K
EX-99.1
y90n 1h43w
6 Nov 19
Verrica Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:18pm
DEF 14A
7z8kkkuz
25 Apr 19
Definitive proxy
8:51am
8-K
EX-99.1
rvcq eji72klenxmnx
7 Mar 19
Verrica Reports Fourth Quarter and Full Year 2018 Financial Results
4:16pm
8-K
EX-99.1
hc8ushy4
7 Nov 18
Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
4:44pm
8-K
EX-99.1
eurmmk8747z
7 Aug 18
Verrica Reports Second Quarter 2018 Financial Results
4:07pm
424B4
9bidf5i ua
15 Jun 18
Prospectus supplement with pricing info
4:15pm
S-1/A
c8z47lrj chp
5 Jun 18
IPO registration (amended)
12:00am